Rosen Law Firm reminds purchasers of Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Insulet made false and misleading statements and failed to disclose defective manufacturing controls and procedures, which created a heightened risk of safety violations or injury. Investors who purchased Insulet securities during the class period may be entitled to compensation through a contingency fee arrangement. Rosen Law Firm highlights its track record in securities class actions, including the largest-ever settlement against a Chinese company and over $438 million recovered for investors in 2019 alone.
Insulet CorporationSecurities class action lawsuit alleges Insulet made false statements and failed to disclose defective manufacturing controls, creating risk of safety violations or injury.